Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
用户Ebw_xPFzAKxY
2个月前
60
10
已关闭
DOI: 10.1016/S2213-8587(25)00216-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858725002165
其他信息:
出版社: Elsevier BV
作者: Filip K Knop; George Kunos; Dror Dicker; Jean-Sebastien Paquette; Louis Aronne; Ofir Frenkel; Thomas Holst-Hansen; Karine Lalonde; Jisoo Lee; Glenn Crater

